Christopher Ritchie

Title: Christopher Ritchie: Pharmaceutical Invention and Patent

Introduction

Christopher Ritchie is an inventor based in Lincoln, New Zealand. His patent work includes a pharmaceutical formulation designed for rectal delivery of 6-thioguanine, a medicine relevant to the treatment of inflammatory bowel disease.

Latest Patents

Ritchie is associated with 1 patent, titled “Pharmaceutical Rectal Suppository Compositions of 6-Thioguanine, Methods of Treatment and/or Methods of Manufacturing.” The invention describes a rectal suppository containing 6-thioguanine, at least one hard fat, and at least one surfactant. The composition may contain about 1 to 9 mg of 6-thioguanine.

The patent also describes a method of preventing, treating, or managing inflammatory bowel disease by administering the suppository to a subject in need. Its manufacturing method involves heating hard fat until liquid, adding a surfactant and 6-thioguanine, and forming the mixture into a suppository. The surfactant may be added before or after the 6-thioguanine.

Career Highlights

Ritchie is associated with Douglas Pharmaceuticals Limited. His patent reflects work on pharmaceutical formulation and manufacturing, with a focus on delivering 6-thioguanine through a rectal suppository.

Collaborations

The listed coworkers associated with Ritchie include Fergus Cameron Binnie and Peter William Surman.

Conclusion

Christopher Ritchie’s patent centers on a 6-thioguanine suppository, its potential use in managing inflammatory bowel disease, and methods for manufacturing the formulation.